Document LKorDY3xL8GyZJ1zED72oV1y5

Cc: From: restrictiePFAS @rivm.nl] Sent: Fri 1/13/2023 3:44:15 PM Subject: RE: [EXT] Antw: PFAS restriction - Annex XV Received: Fri 1/13/2023 3:44:22 PM JRE From: erivm.nl> Sent: Friday, January 13, 2023 4:43 PM BEER To: SRE Cc: restrictiePFAS < 5.1.2 @ chemours.com> @rivm.nl> Subject: [EXT] Antw: PFAS restriction - Annex XV [External email. Confirm links and attachments before opening. Hoi BES ; Dankjewel! En ook nog de beste wensen voor jou. En inderdaad, ECHA doet een prepublicatie op 7 februari. Het ericht van ECHA geeft dat aan: https://www.linkedin.com/posts/european-chemicals-agency restriction-proposal-for-per-and-polyfluoroalkyl-ugcPost7019668214984978432-b5jU?utm source=share&utm medium=member android Vriendelijke groet, JEXEMo van: EERIE" hemours.com> Verzonden: vrijdag 13 januari 2023 14:48 IEEE @ rivin n> aan: EXE Onderwerp: FW: PFAS restriction - Annex XV BE Hi Nog de beste wensen. Nav dit persbericht: mooie prestatie! Ik had nog wel een vraag; tijdens het laats gehouden collaboration platform van FPP4EU in december, is gemeld (weet niet meer door wie) dat er een `pre-publicatie' openbaar zou worden gemaakt. Ik dacht gehoord te hebben dat dit eind januari zou zijn. Heb ik het mis? Ik hoor wel. Met vriendelijke groeten, From: Sent: Friday, January 13, 2023 2:28 PM @chemours.com>; chemours.com>; BE @chemours.com>; 5.1.2e an @chemours.com) cor; chemoEuN rE s @chemours.com> Subject: PFAS restriction - Annex XV Dear all, in a press release, RIVM confirmed that the Annex XV dossier has been submitted today: Proposed European PFAS ban officially submitted Publication date 01/13/2023 - 14:00 The Netherlands, Germany, Denmark, Sweden and Norway today took the first formal step towards a European ban on per- and polyfluoroalkyl substances (PFAS) by jointly submitting a restriction proposal to the European Chemicals Agency (ECHA). The restriction proposal seeks a ban on both the use and production of PFAS in order to reduce the risks these substances pose to humans and the environment. If passed, it will constitute the largest substances ban ever in Europe. The ban will also be complex, as more than 10,000 different types of PFAS exist. These are used in a multitude of products. Ban in three stages There are three stages in the process of banning the use of PFAS. The first stage -- the submission of a restriction proposal -- was completed today. This stage involved the consultation of scientific literature and various requests for information from relevant businesses, public authorities and organisations. The next stage, to commence after publication of the restriction proposal (on 7 February), is a public consultation by ECHA. Anyone may submit information or state an opinion about the proposal. This information will be incorporated. Afterwards, two ECHA scientific committees -- the Risk Assessment Committee (RAC) and the SocioEconomic Assessment Committee (SEAC) -- will present their opinions. Finally, the European Commission will draft a definitive proposal for a Member State vote. The ban is subsequently expected to enter into force in 2025. 2965843 PFAS harmful to humans and animals Denmark, Germany, the Netherlands, Norway and Sweden have been working together to draft a proposal for a European PFAS ban since 2019. Many PFAS barely degrade in the environment or do not degrade at all. PFAS are known to have potentially harmful effects on human health. They can also be harmful to nature. The precise effects vary depending on the specific PFAS. One PFAS may spread faster or be more harmful than another. Furthermore, there are many PFAS about which scientists know little if anything, so it is still unclear if they have adverse properties. Seperately, it was conformed that the start of the public consultation is planned for March 22 Chemours Netherlands B.V. Baanhoekweg 22 3313 LA Dordrecht CcChemours' See our web page at http:/ /www.chemourz.com for a full directory of Chemours sites, staff, services and career opportunities. This communication is for use by the intended recipient and contains information that may be privileged, confidential or copyrighted under applicable law. If you are not the intended recipient, you are hereby formally notified that any use, copying or distribution of this e-mail, in whole or in part, is strictly prohibited. Please notify the sender by retum e-mail and delete this e-mail from your system. Unless explicitly and conspicuously designated as" E-Contract Intended", thies- mail does not constitute a contract offer, a contract amendment, or an acceptance of a contract offer. This e-mail does not constitute a consent to the use of sender's contact information for direct marketing purposes or for transfers of data to third parties. Chemours Netherlands B.V. Baanhoekweg 22 3313 LA Dordrecht Statutaire zetel: Dordrecht Dossiernummer: 54013445 This communication is for use by the intended recipient and contains information that may be privileged, confidential or copyrighted under applicable law. If you are not the intended recipient, you are hereby formally notified that any use, copying or distribution of this e-mail, in whole or in part, is strictly prohibited. Please notify the sender by return e-mail and delete this e-mail from your system. Unless explicitly and conspicuously designated as "E-Contract Intended", this e-mail does not constitute a contract offer, a contract amendment, or an acceptance of a contract offer. This e-mail does not constitute a consent to the use of sender's contact information for direct marketing purposes or for transfers of data to third parties. https://www.chemours.com/en/email-disclaimer Dit bericht kan informatie bevatten die niet voor u is bestemd. Indien u niet de geadresseerde bent ofdit bericht abusievelijk aan u is verzonden, wordt u verzocht dat aan de afzender te melden en het bericht te verwijderen. Het RIVM aanvaardt geen aansprakelijkheid voor schade, van welke aard ook, die verband houdt met risico's verbonden aan het elektronisch verzenden van berichten. www.rivim.nl De Zorg voor morgen begint vandaag message for you. This may contain information that is not intended Ifyou are not the addressee or if this message was sent to you by mistake, you are requested to inform the sender and delete no for damage the message. RIVM accepts liability of any kind resulting from the risks inherent in the electronic transmission ofmessages. www. rivin.nl/en Committed to health and sustainability Chemours Netherlands B.V. Baanhoekweg 22 3313 LA Dordrecht Statutaire zetel: Dordrecht Dossiernummer: 54013445 This communication is for use by the intended recipient and contains information that may be privileged, confidential or copyrighted under applicable law. If you are not the intended recipient, you are hereby formally notified that any use, copying or distribution of this e-mail, in whole or in part, is strictly prohibited. Please notify the sender by return e-mail and delete this e-mail from your system. Unless explicitly and conspicuously designated as "E-Contract Intended", this email does not constitute a contract offer, a contract amendment, or an acceptance of a contract offer. This e-mail does not constitute a consent to the use of sender's contact information for direct marketing purposes or for transfers of data to third parties. https://www.chemours.com/en/email-disclaimer